Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025)
Carlsmed's (CARL) quarterly Net Equity Issued and Repurchased came in at $11.9 million in Q1 2025, up 36218.18% on a QoQ basis from -$33000.0 in Q4 2024.
Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Carlsmed (CARL) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $11.9 million in Q1 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $11.9 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $11.9 million (changed N/A YoY) and the FY2025 annual result came in at $11.9 million, down 77.19% from the prior year.
- Net Equity Issued and Repurchased climbed to $11.9 million in Q1 2025, from -$33000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $14.0 million in Q3 2024 to a low of -$132000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Carlsmed | 389.87 Mn | 276.57 Mn | 14.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 11.92 Mn |
| Mar 31, 2025 | 11.92 Mn |
| Dec 31, 2024 | -33,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 14.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | -132,000.00 |
| Jun 30, 2024 | -132,000.00 |